Price chart (1D to 10Y)
Licensed market data — shown to members, not published to the open web.
Portfolio · 30 Jun 2026
From the fund’s own N-PORT filingThe fund’s disclosed portfolio, not an index membership list. Showing the largest 25 of 39 positions. The ten largest identified positions carry 30.7% of the portfolio.
| # | Holding | Sector | Country | Weight | Filed value |
|---|---|---|---|---|---|
| 1 | Definium Therapeutics Inc DFTX | Healthcare | United States | 4.77% | $64.44K |
| 2 | Neuren Pharmaceuticals Ltd | — | Australia | 3.23% | $43.70K |
| 3 | LifeStance Health Group Inc LFST | Healthcare | United States | 3.04% | $41.10K |
| 4 | Otsuka Holdings Co Ltd | — | Japan | 2.95% | $39.88K |
| 5 | Acadia Healthcare Co Inc ACHC | Healthcare | United States | 2.90% | $39.21K |
| 6 | ACADIA Pharmaceuticals Inc ACAD | Healthcare | United States | 2.89% | $39.06K |
| 7 | MapLight Therapeutics Inc |
Source: SEC filings. Information and analytics, not investment advice.